Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07107139 · ClinicalTrials.gov registry record · NA
Influence of Authorized Smokeless Tobacco Product Modified Risk Claims II: Laboratory Assessment of Sensory and Subjective Effects
A NA study of Smokeless Tobacco, sponsored by Roswell Park Cancer Institute.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT07107139: Recruiting NA study of Smokeless Tobacco, sponsored by Roswell Park Cancer Institute.
NCT07107139 is a NA study of Smokeless Tobacco that is actively recruiting participants, run by Roswell Park Cancer Institute. The registered enrollment target is 50 participants, below the 227-participant average among 3 other Smokeless Tobacco trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07107139, a NA study of Smokeless Tobacco, is actively recruiting participants, sponsored by Roswell Park Cancer Institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This study seeks to measure the effects of smokeless tobacco product risk messages on sensory experiences and future intentions to use.
Primary Outcome
assessed with a 0-100 visual analog scale - anchored by word descriptors at each end.
Conditions Studied
Interventions
- OTHER Copenhagen group
- OTHER Snus group
Study Locations (1)
New York
- Roswell Park - Buffalo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2026-03-30 |
| Est. Completion | 2027-03-01 |
| Phase | NA |
What NCT07107139 shows while recruiting
NCT07107139 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 227-participant average among 3 other Smokeless Tobacco trials with a reported enrollment target (78% lower).
The record links to 1 condition, with Smokeless Tobacco appearing as the primary indexed condition, and to 2 interventions - of which Copenhagen group is the first listed.
NCT07107139 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT07107139 about?
NCT07107139 is a clinical study titled "Influence of Authorized Smokeless Tobacco Product Modified Risk Claims II: Laboratory Assessment of Sensory and Subjective Effects". This study seeks to measure the effects of smokeless tobacco product risk messages on sensory experiences and future intentions to use.
What is the current status of trial NCT07107139?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2026-03-30. Estimated completion is 2027-03-01.
What conditions does trial NCT07107139 study?
This clinical trial studies the following conditions: Smokeless Tobacco.
What interventions are being tested in trial NCT07107139?
The interventions under investigation include: Copenhagen group (OTHER), Snus group (OTHER).
Who is sponsoring clinical trial NCT07107139?
This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07107139 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smokeless Tobacco
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI